Drug Pipeline

Drug Pipeline Market Research Reports

1 . Drug Pipeline Market Research Reports Analysis and Trends

Discovering and bringing new drugs to mainstream commercial market typically takes an average of 10-15 years of research and clinical development efforts. Drug developers need to make sure safe and effective drug available for patient in quick time. The first step is to target the protein available in the patient’s body that is associated with microorganism causing a disease, through tracking of cellular network of proteins an appropriate target for a drug is selected. Through a series of trials, right drug candidate got chosen.
 
According to “NOVARTIS”, bringing a new drug in market takes 14 years of research and cost around USD 2 billion, 10K+ clinical trials out of these, one leads to successful drug development.
Titlesort descending Published Pages Price
Alpha- Antitrypsin Deficiency - Pipeline Review, H1 2019 Mar 29 2019 89 USD 2,000.00
Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2018 Aug 21 2018 83 USD 2,000.00
Alpha-1 Antitrypsin Deficiency (A1AD) (Genitourinary Disorders) - Drugs In Development, 2021 Jul 30 2021 138 USD 2,000.00
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline Review, H1 2020 Feb 28 2020 106 USD 2,000.00
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline Review, H2 2019 Nov 29 2019 99 USD 2,000.00
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline Review, H2 2020 Aug 31 2020 118 USD 2,000.00
Alpha-1 Antitrypsin Deficiency (A1AD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Apr 29 2022 124 USD 2,000.00
Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 Apr 30 2021 35 USD 2,000.00
Alport Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 42 USD 2,000.00
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021 Jun 30 2021 2055 USD 2,500.00
Alzheimer's Disease - Pipeline Review, H1 2018 Feb 20 2018 1203 USD 2,500.00
Alzheimer's Disease - Pipeline Review, H1 2019 Apr 29 2019 1429 USD 2,500.00
Alzheimer's Disease - Pipeline Review, H1 2020 Feb 28 2020 1716 USD 2,500.00
Alzheimer's Disease - Pipeline Review, H2 2018 Aug 7 2018 1333 USD 2,500.00
Alzheimer's Disease - Pipeline Review, H2 2019 Nov 29 2019 1641 USD 2,500.00
Alzheimer's Disease - Pipeline Review, H2 2020 Aug 31 2020 1785 USD 2,500.00
Alzheimer's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Apr 1 2022 1715 USD 2,500.00
Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) - Drugs in Development, 2021 Apr 30 2021 35 USD 3,000.00
Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 39 USD 2,500.00
Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) - Drugs in Development, 2021 Apr 30 2021 55 USD 3,000.00
Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 52 USD 2,500.00
Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021 Apr 30 2021 30 USD 2,000.00
Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players May 2 2022 107 USD 2,000.00
Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase or Aminopeptidase M or Microsomal Aminopeptidase or gp150 or CD13 or ANPEP or EC 3.4.11.2) - Drugs in Development, 2021 Apr 30 2021 35 USD 3,000.00
Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase or Aminopeptidase M or Microsomal Aminopeptidase or gp150 or CD13 or ANPEP or EC 3.4.11.2) - Pipeline Review, H1 2018 May 8 2018 53 USD 3,500.00
Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase or Aminopeptidase M or Microsomal Aminopeptidase or gp150 or CD13 or ANPEP or EC 3.4.11.2) - Pipeline Review, H2 2018 Nov 13 2018 55 USD 3,500.00
Aminopeptidase N - Pipeline Review, H2 2019 Dec 27 2019 58 USD 3,500.00
Amyloid Beta A4 Protein (ABPP or APPI or Alzheimer Disease Amyloid Protein or Amyloid Precursor Protein or Amyloid Beta Precursor Protein or Cerebral Vascular Amyloid Peptide or Prea4 or Protease Nexin II or APP) - Drugs in Development, 2021 Apr 30 2021 210 USD 3,500.00
Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021 Mar 31 2021 304 USD 2,000.00
Amyloidosis - Pipeline Review, H1 2019 Feb 1 2019 199 USD 2,000.00
Amyloidosis - Pipeline Review, H1 2020 Jan 31 2020 226 USD 2,000.00
Amyloidosis - Pipeline Review, H2 2018 Jul 17 2018 196 USD 2,000.00
Amyloidosis - Pipeline Review, H2 2019 Nov 11 2019 217 USD 2,000.00
Amyloidosis - Pipeline Review, H2 2020 Jul 31 2020 241 USD 2,000.00
Amyloidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Mar 31 2022 239 USD 2,000.00
Amyotrophic Lateral Sclerosis (Central Nervous System) - Drugs in Development, 2021 Sep 30 2021 945 USD 2,500.00
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2020 May 30 2020 759 USD 2,500.00
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2018 Oct 30 2018 551 USD 2,000.00
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2019 Dec 16 2019 707 USD 2,500.00
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020 Nov 30 2020 868 USD 2,500.00
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Sep 30 2022 672 USD 2,500.00
Anal Cancer (Oncology) - Drugs In Development, 2021 Jul 30 2021 813 USD 2,000.00
Anal Cancer - Pipeline Review, H1 2018 Feb 20 2018 237 USD 2,000.00
Anal Cancer - Pipeline Review, H1 2019 Mar 29 2019 390 USD 2,000.00
Anal Cancer - Pipeline Review, H1 2020 Feb 28 2020 525 USD 2,000.00
Anal Cancer - Pipeline Review, H2 2018 Aug 14 2018 304 USD 2,000.00
Anal Cancer - Pipeline Review, H2 2019 Nov 18 2019 475 USD 2,000.00
Anal Cancer - Pipeline Review, H2 2020 Aug 31 2020 589 USD 2,000.00
Anal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Apr 29 2022 216 USD 2,000.00
Anal Fissure (Gastrointestinal) - Drugs in Development, 2021 Apr 30 2021 30 USD 2,000.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected